发明名称 CYCLOALKANE DERIVATIVE.
摘要 <p>Provided is a drug for the treatment and/or prevention of pain or a drug for the treatment and/or prevention of sodium channel-mediated diseases. A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: Ar1, Ar2: heteroaryl group, aryl group; R1, R2, R3: hydrogen atom, halogen atom, C1-C6 alkyl group, halogenated C1-C6 alkyl group, hydroxy C1-C6 alkyl group, C1-C6 alkoxy C1-C6 alkyl group or C3-C7 cycloalkyl group, cyano group; R4, R5: hydrogen atom, halogen atom, C1-C6 alkyl group, halogenated C1-C6 alkyl group, hydroxyl group, hydroxy C1-C6 alkyl group, C1-C6 alkoxy C1-C6 alkyl group, C3-C7 cycloalkyl group, C1-C6 alkoxy group; n: integer from 1 to 3; the heteroaryl group and aryl group may have one or two groups selected independently from a halogen atom, C1-C6 alkyl group, halogenated C1-C6 alkyl group, hydroxyl group, hydroxy C1-C6 alkyl group, C1-C6 alkoxy C1-C6 alkyl group, C3-C7 cycloalkyl group, carboxyl group, cyano group, amino group, C1-C3 alkylamino group, and di C1-C3 alkylamino group; in the case of two, the two may be the same or different.</p>
申请公布号 MX2014009637(A) 申请公布日期 2015.06.23
申请号 MX20140009637 申请日期 2013.02.08
申请人 DAIICHI SANKYO COMPANY, LIMITED 发明人 SHINOZUKA, TSUYOSHI;DOMON, YUKI;KOBAYASHI, HIROYUKI;SUZUKI, SAYAKA;TANAKA, KYOSUKE;KIMOTO, HIROKO
分类号 C07D285/08;A61K31/427;A61K31/433;A61K31/506;A61P19/02;A61P19/06;A61P21/02;A61P25/04;A61P25/06;A61P25/08;A61P25/22;A61P29/00;A61P43/00;C07D401/12;C07D403/12;C07D417/12 主分类号 C07D285/08
代理机构 代理人
主权项
地址